National Momentum for Psychedelic Therapy

Colorado Expands Access via Proposition 122

Colorado voters approved Proposition 122 in 2022, decriminalizing certain psychedelics and establishing supervised healing centers for adults. Proposition 122

Federal Support: H.R. 2623 – Innovative Therapies Centers of Excellence Act

Introduced in 2025, H.R. 2623 aims to establish VA centers focused on innovative treatments, including psychedelics, for veterans. H.R. 2623

Oregon Leads with Measure 109

In 2020, Oregon became the first state to legalize regulated psilocybin services through licensed centers, offering new hope for those with depression, PTSD, and addiction. Measure 109

About the Law & Legislation

Our goal is to advance the legal access, responsible use, and ethical regulation of psychedelic medicine in Missouri and federally. We work with regulators, industry leaders, and stakeholders to ensure patient access and harm reduction through strong policy frameworks.

By supporting clinical research, we help drive FDA approvals, rescheduling efforts, and compassionate access pathways. We also advocate for the legal production of botanical psychedelics while protecting Indigenous rights to sacred medicine traditions.

Current Missouri Legislation

House Bill No. 829 – Psilocybin Therapy Pilot Program

Senate Bill No. 90 – Establishing Access to Psychedelic-Assisted Care

This bill proposes the creation of a pilot program authorizing the supervised therapeutic use of psilocybin for conditions like PTSD, treatment-resistant depression, and substance use disorders.

It is a major step forward in expanding safe, science-backed mental health options for Missourians. Link to Bill

Senate Bill 90 supports the use of certain psychedelics, including psilocybin, for medical treatment in regulated environments.

It reflects Missouri’s growing commitment to innovation in behavioral health policy. Link to Bill